A recent study suggests that patients who discontinue blockbuster slimming jabs like Wegovy and Mounjaro may regain shed pounds far faster than those who halt conventional lifestyle regimens.
Findings released in a major health publication shows that while obese people can lose a large proportion of their body weight while using the jabs, the mass returns at an estimated rate of nearly a kilo each month after stopping.
"Users buying these drugs must be aware of the potential of fast rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.
That rate of recovery means a return to starting weight within about a year and a half.
Comparing Approaches
The study, which examined 37 of studies involving thousands of participants, contrasted the effects of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through diet and exercise generally experience a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Regain
Nutrition scientists propose the way of the drugs is key to understanding the accelerated rebound.
These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations far above than normal may cause the body to produce less of its own natural hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Issue?
Health authorities advise the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals argue that, considering the likelihood of weight regain, the treatment is often life-long.
This perspective is supported by pharmaceutical companies, who note that the results "highlight the long-term character of excess weight," comparing it to managing diseases like high blood pressure.
Patient Accounts
Users who have stopped the jabs describe a intense resurgence of hunger.
"It was like something flipping and you're instantly ravenous," recalled a patient.
The struggle is compounded if users have not adopted lasting dietary or behavioural modifications during treatment.
Growing Adoption
Figures suggest that millions of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians stress that while these medications are effective tools for shedding pounds, they are not a permanent fix and maintained weight loss hinges on combined behavioural changes.
